ACIP Presentation Slides: February 4, 2022 Meeting
Note: These files are not yet 508
Slides will be added as they become available.
February 4, 2022
Welcome & Introductions
- Introduction
Dr. G Lee
Dr. M Wharton
Coronavirus Disease (COVID-19) Vaccines
- Introduction pdf icon[13 pages]
Dr. M Daley
- mRNA 1273 COVID-19 vaccine BLA safety and efficacy data pdf icon[30 pages]
Dr. R Das - Updates on myocarditis and pericarditis following Moderna COVID-19 vaccination pdf icon[19 pages]
Dr. T Shimabukuro - Update on myocarditis outcomes: MOVING pdf icon[32 pages]
Dr. I Kracalic - VaST assessment pdf icon[13 pages]
Dr. K Talbot - GRADE: Moderna COVID-19 vaccine pdf icon[49 pages]
Dr. M Wallace - EtR Framework: Moderna COVID-19 vaccine primary series in adults ≥18 years of age pdf icon[94 pages]
Dr. S Oliver - Updates to Clinical Considerations pdf icon[21 pages]
Dr. E Hall - Canadian experience and evidence with COVID-19 vaccine primary series extended intervals pdf icon[23 pages]
Dr. M Tunis, Dr. B Warshawsky, Ms. S Ogunnaike-Cooke - VSD: Myocarditis after Moderna and Pfizer/BioNTech COVID-19 vaccine pdf icon[28 pages]
Dr. N Klein - Myocarditis and COVID-19 vaccine intervals: International data and policies pdf icon[35 pages]
Ms. D Moulia - Summary and Work Group Interpretation: Extended intervals for mRNA COVID-19 vaccines pdf icon[25 pages]
Dr. S Oliver